Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Ovarian Neoplasms"" wg kryterium: Temat


Tytuł:
Mesonephric-like adenocarcinoma of the ovary.
Autorzy:
Yang Y; Dalian Medical University, Dalian, 116000, PR China.
Zhao M; Dalian Medical University, Dalian, 116000, PR China.
Jia Q; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Tang H; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Xing T; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Li Y; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Tang B; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Xu L; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Wei W; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Zheng H; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Shi R; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Xia B; Department of Gynecological Oncology, Division of Life Sciences and Medicine, the First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, Hefei, 230031, PR China. .
Chen J; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Mar 05; Vol. 17 (1), pp. 57. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/therapy
Adenocarcinoma*/diagnosis
Adenocarcinoma*/therapy
Female ; Humans ; Middle Aged ; Pelvis ; Carboplatin
Czasopismo naukowe
Tytuł:
Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients.
Autorzy:
Bourgeois J; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium. Electronic address: .
Peacock HM; Belgian Cancer Registry, Koningsstraat 215, Bus7, Brussels, B-1210, Belgium.
Savoye I; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium.
De Gendt C; Belgian Cancer Registry, Koningsstraat 215, Bus7, Brussels, B-1210, Belgium.
Leroy R; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium.
Silversmit G; Belgian Cancer Registry, Koningsstraat 215, Bus7, Brussels, B-1210, Belgium.
Stordeur S; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium.
de Sutter P; Department Gynaecology-Oncology, UZ Brussel - VUB, Brussels, B-1210, Belgium.
Goffin F; Department of Obstetrics and Gynaecology, University Hospital of Liège, Liège, Belgium.
Luyckx M; Service de Gynécologie et Andrologie and Institut Roi Albert II, Cliniques Universitaires Saint-Luc, UCLouvain, Brussel, Belgium.
Orye G; Department of Obstetrics and Gynecology, Jessa Hospital, Hasselt, Belgium.
Van Dam P; Division of Gynecological Oncology, Multidisciplinary Oncologic Centre, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium.
Van Gorp T; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium.
Verleye L; Belgian Health Care Knowledge Centre (KCE), Kruidtuinlaan 55, Brussels, B-1000, Belgium.
Pokaż więcej
Źródło:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2024 Mar; Vol. 50 (3), pp. 107978. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/surgery
Ovarian Neoplasms*/pathology
Humans ; Female ; Belgium/epidemiology ; Lymph Nodes/pathology ; Lymph Node Excision/methods ; Hospitals, High-Volume ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements.
Autorzy:
Tavares V; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP), Pathology and Laboratory Medicine Department, Clinical Pathology (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal.; ICBAS-Instituto de Ciências Biomédicas Abel Salazar, University of Porto, 4050-313 Porto, Portugal.
Marques IS; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP), Pathology and Laboratory Medicine Department, Clinical Pathology (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.
Melo IG; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP), Pathology and Laboratory Medicine Department, Clinical Pathology (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal.
Assis J; Clinical Research Unit, Research Center of IPO Porto (CI-IPOP), (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.
Pereira D; Oncology Department, Portuguese Institute of Oncology of Porto (IPOP), 4200-072 Porto, Portugal.
Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP), Pathology and Laboratory Medicine Department, Clinical Pathology (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal.; Faculty of Medicine, University of Porto, 4200-072 Porto, Portugal.; ICBAS-Instituto de Ciências Biomédicas Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal.; Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 03; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Ovarian Neoplasms*/therapy
Ovarian Neoplasms*/drug therapy
Genital Neoplasms, Female*
Humans ; Female ; Quality of Life ; Neoplasm Recurrence, Local ; Biomarkers
Czasopismo naukowe
Tytuł:
Childhood body fatness and the risk of epithelial ovarian cancer: A population-based case-control study in Montreal, Canada.
Autorzy:
L'Espérance K; Université de Montréal Hospital Research Centre (CRCHUM), 850, rue Saint-Denis, Montréal, Québec H2X 0A9, Canada; Department of Social and Preventive Medicine, Université de Montréal, 7101, avenue du Parc, Montréal, Québec H3N 1X9, Canada.
Abrahamowicz M; Centre for Outcomes Research and Evaluation and Division of Clinical Epidemiology, 1001, boulevard Décarie, Montréal, Québec H4A 3J1, Canada; Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine and Health Sciences, McGill University, 2001, avenue McGill College, Montréal, Québec H3A 1Y7, Canada.
O'Loughlin J; Université de Montréal Hospital Research Centre (CRCHUM), 850, rue Saint-Denis, Montréal, Québec H2X 0A9, Canada; Department of Social and Preventive Medicine, Université de Montréal, 7101, avenue du Parc, Montréal, Québec H3N 1X9, Canada.
Koushik A; Université de Montréal Hospital Research Centre (CRCHUM), 850, rue Saint-Denis, Montréal, Québec H2X 0A9, Canada; Department of Social and Preventive Medicine, Université de Montréal, 7101, avenue du Parc, Montréal, Québec H3N 1X9, Canada; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, 5100 de Maisonneuve Blvd. West, Suite 720, Montréal, Québec H4A 3T2, Canada; St. Mary's Research Centre, 3830 Lacombe Ave, Montréal, Québec, H3T 1M5, Canada. Electronic address: .
Pokaż więcej
Źródło:
Preventive medicine [Prev Med] 2024 Jan; Vol. 178, pp. 107794. Date of Electronic Publication: 2023 Dec 10.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/etiology
Ovarian Neoplasms*/pathology
Neoplasms, Glandular and Epithelial*/epidemiology
Neoplasms, Glandular and Epithelial*/etiology
Child ; Adult ; Humans ; Female ; Carcinoma, Ovarian Epithelial/epidemiology ; Carcinoma, Ovarian Epithelial/etiology ; Case-Control Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
Autorzy:
Neil AJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Li YY; Dana Farber Cancer Institute, Boston, MA, USA.
Hakam A; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA.
Nucci MR; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Parra-Herran C; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2024 Jan; Vol. 84 (2), pp. 369-380. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/genetics
Uterine Cervical Neoplasms*/diagnosis
Papillomavirus Infections*/complications
Adenocarcinoma*/pathology
Adenocarcinoma in Situ*
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/secondary
Female ; Humans
Czasopismo naukowe
Tytuł:
Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis.
Autorzy:
Zhu Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Yang Q; Department of Pathology, Tangshan Cancer Hospital, Tangshan, China.
Liu K; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Cao H; Department of Oncology, Chenzhou First People's Hospital, Chenzhou, China.
Zhu H; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China. .
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2024 Jan; Vol. 35 (1), pp. e2. Date of Electronic Publication: 2023 Jul 05.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Phthalazines*
Piperazines*
Humans ; Female ; Bevacizumab/therapeutic use ; Cost-Effectiveness Analysis ; Cost-Benefit Analysis ; Carcinoma, Ovarian Epithelial
Czasopismo naukowe
Tytuł:
Top advances of the year: Ovarian cancer.
Autorzy:
Lumish MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kohn EC; National Cancer Institute, Bethesda, Maryland, USA.
Tew WP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pokaż więcej
Źródło:
Cancer [Cancer] 2024 Mar 15; Vol. 130 (6), pp. 837-845. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Review; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Ovarian Neoplasms*/pathology
Antineoplastic Agents*/therapeutic use
Immunoconjugates*/therapeutic use
Female ; Humans ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Carcinoma, Ovarian Epithelial/drug therapy ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Tytuł:
Implementing MyChoice® CDx HRD testing for the Nordics: lessons from 2021 to 2023.
Autorzy:
Korsholm LM; Center for Genomic Medicine, Copenhagen University Hospital - Rigshospitalet, 2100 Copenhagen, Denmark.
Broecker V; Department of Clinical Pathology, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
Mirza MR; Department of Oncology, Rigshospitalet, Copenhagen University Hospital - Rigshospitalet, 2100 Copenhagen, Denmark.
Rossing M; Center for Genomic Medicine, Copenhagen University Hospital - Rigshospitalet, 2100 Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. .
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Mar 14; Vol. 63, pp. 70-75. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/drug therapy
Antineoplastic Agents*/therapeutic use
Female ; Humans ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Finland ; Norway
Czasopismo naukowe
Tytuł:
Mucin-producing tumors of the ovary--preoperative differentiation between metastatic ovarian mucinous carcinoma and primary mucinous malignant tumors.
Autorzy:
Cai SQ; Department of Radiology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Xvhui District, Shanghai, PR China.; Shanghai Institute of Medical Imaging, Xvhui District, Shanghai, PR China.; Department of Cancer Center, Zhongshan Hospital, Fudan University, Xvhui District, Shanghai, PR China.
Wu MR; Department of Radiology, Zhongshan Hospital Fudan University Xiamen Branch, Jinhu Road No.668, Huli District, 361015, Xiamen, Fujian, PR China.; Xiamen Municipal Clinical Research Center for Medical Imaging, Xiamen, China.; Xiamen Key Clinical Specialty for Radiology, Xiamen, China.
Ma XL; Department of Radiology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Xvhui District, Shanghai, PR China.; Shanghai Institute of Medical Imaging, Xvhui District, Shanghai, PR China.; Department of Cancer Center, Zhongshan Hospital, Fudan University, Xvhui District, Shanghai, PR China.
Lu JJ; Department of Radiology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Xvhui District, Shanghai, PR China.; Shanghai Institute of Medical Imaging, Xvhui District, Shanghai, PR China.; Department of Cancer Center, Zhongshan Hospital, Fudan University, Xvhui District, Shanghai, PR China.
Qiang JW; Department of Radiology, Jinshan Hospital, Shanghai Medical College, Fudan University, Jinshan District, Shanghai, PR China.
Guan YY; Department of Pathology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, PR China.
Zeng MS; Department of Radiology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Xvhui District, Shanghai, PR China. .; Shanghai Institute of Medical Imaging, Xvhui District, Shanghai, PR China. .; Department of Cancer Center, Zhongshan Hospital, Fudan University, Xvhui District, Shanghai, PR China. .
Zhou JJ; Department of Radiology, Zhongshan Hospital Fudan University Xiamen Branch, Jinhu Road No.668, Huli District, 361015, Xiamen, Fujian, PR China. .; Xiamen Municipal Clinical Research Center for Medical Imaging, Xiamen, China. .; Xiamen Key Clinical Specialty for Radiology, Xiamen, China. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Mar 13; Vol. 17 (1), pp. 59. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/surgery
Adenocarcinoma, Mucinous*/diagnostic imaging
Adenocarcinoma, Mucinous*/surgery
Female ; Humans ; Carcinoma, Ovarian Epithelial/diagnosis ; Mucins ; Diagnosis, Differential
Czasopismo naukowe
Tytuł:
Using online search activity for earlier detection of gynaecological malignancy.
Autorzy:
Barcroft JF; Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0HS, UK.
Yom-Tov E; Microsoft Research, Hoshaya, Israel.
Lampos V; Department of Computer Science, University College London, London, UK.
Ellis LB; Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0HS, UK.
Guzman D; Department of Computer Science, University College London, London, UK.
Ponce-López V; Department of Computer Science, University College London, London, UK.
Bourne T; Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0HS, UK.
Cox IJ; Department of Computer Science, University College London, London, UK.; Computer Science, University of Copenhagen, Copenhagen, Denmark.
Saso S; Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0HS, UK. .
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2024 Mar 11; Vol. 24 (1), pp. 608. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Genital Neoplasms, Female*/diagnosis
Ovarian Neoplasms*
Humans ; Female ; Young Adult ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Prospective Studies ; Early Detection of Cancer ; London/epidemiology
Czasopismo naukowe
Tytuł:
Association between the quantitative characteristics of dual-energy spectral CT and cytoreduction surgery outcome in patients with advanced epithelial ovarian cancers: A prospective observational study.
Autorzy:
Xu X; Department of Diagnostic Imaging, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen Y
Zhang X
Wang Y
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2024 Mar 08; Vol. 103 (10), pp. e37437.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/surgery
Ovarian Neoplasms*/pathology
Humans ; Female ; Aged ; Carcinoma, Ovarian Epithelial/diagnostic imaging ; Carcinoma, Ovarian Epithelial/surgery ; Carcinoma, Ovarian Epithelial/pathology ; Cytoreduction Surgical Procedures ; Prospective Studies ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation.
Autorzy:
Yang X; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, 250012, PR China.
Hu X; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Yin J; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Li W; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shihezi University Shihezi, Xinjiang, 832000, PR China.
Fu Y; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Yang B; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Fan J; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Lu F; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Qin T; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Kang X; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Zhuang X; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China.
Li F; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Shihezi University Shihezi, Xinjiang, 832000, PR China.
Xiao R; Department of Gynecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, PR China.
Shi T; Ovarian Cancer Program, Department of Gynecologic Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, PR China.
Song K; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, 250012, PR China.
Li J; Department of Gynecologic Oncology, Sun Yat-sen Memorial Hospital, 33 Yingfeng Road, Guangzhou, 510000, PR China. .
Chen G; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China. .; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China. .
Sun C; Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China. .; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei, PR China. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2024 Mar 07; Vol. 15 (1), pp. 2089. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Hyperthermia, Induced*
Ovarian Neoplasms*/therapy
Ovarian Neoplasms*/pathology
Female ; Humans ; CDC2 Protein Kinase/metabolism ; Cell Cycle Proteins/metabolism ; Protein-Tyrosine Kinases/metabolism ; Multiomics ; Mitosis
Czasopismo naukowe
Tytuł:
Contrast-enhanced CT radiomics for preoperative prediction of stage in epithelial ovarian cancer: a multicenter study.
Autorzy:
Leng Y; Department of Radiology, the Second Affiliated Hospital of Nanchang University, Minde Road No. 1, 330006, Nanchang, Jiangxi Province, China.
Kan A; Department of Radiology, the Second Affiliated Hospital of Nanchang University, Minde Road No. 1, 330006, Nanchang, Jiangxi Province, China.
Wang X; Department of Radiology, the Second Affiliated Hospital of Nanchang University, Minde Road No. 1, 330006, Nanchang, Jiangxi Province, China.
Li X; Department of Radiology, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi, China.
Xiao X; Department of Radiology, the Second Affiliated Hospital of Nanchang University, Minde Road No. 1, 330006, Nanchang, Jiangxi Province, China.
Wang Y; Clinical and Technical Support, Philips Healthcare, Shanghai, China.
Liu L; Department of Radiology, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China. .
Gong L; Department of Radiology, the Second Affiliated Hospital of Nanchang University, Minde Road No. 1, 330006, Nanchang, Jiangxi Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 06; Vol. 24 (1), pp. 307. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/surgery
Radiomics*
Female ; Humans ; Algorithms ; Carcinoma, Ovarian Epithelial/diagnostic imaging ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
A real-world study of treatment patterns following disease progression in epithelial ovarian cancer patients undergoing poly-ADP-ribose polymerase inhibitor maintenance therapy.
Autorzy:
Zhang N; Gynecology Department, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Ministry of Education of People's Republic of China, Beijing, 100142, China.
Zheng H; Gynecology Department, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Ministry of Education of People's Republic of China, Beijing, 100142, China. zheng_111_.
Gao Y; Gynecology Department, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Ministry of Education of People's Republic of China, Beijing, 100142, China.
Shu T; Gynecology Department, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Ministry of Education of People's Republic of China, Beijing, 100142, China.
Wang H; Gynecology Department, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Ministry of Education of People's Republic of China, Beijing, 100142, China.
Cai Y; Gynecology Department, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Ministry of Education of People's Republic of China, Beijing, 100142, China.
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Mar 05; Vol. 17 (1), pp. 55. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/genetics
Humans ; Female ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; BRCA1 Protein/genetics ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Retrospective Studies ; BRCA2 Protein/genetics ; Disease Progression ; Adenosine Diphosphate Ribose
Czasopismo naukowe
Tytuł:
Presentation and treatment of two cases of malignant struma ovarii.
Autorzy:
Obeidat RA; Department of Obstetrics and Gynecology, Faculty of Medicine, Jordan University of Science and Technology, P. O. Box: 3030, Irbid, 22110, Jordan. obeidat_.
Alshwayyat S; Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Alshwayyat TA; Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Rjoop A; Department of Pathology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Sharqiah QM; Department of Pathology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2024 Mar 05; Vol. 24 (1), pp. 158. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Dermoid Cyst*
Struma Ovarii*/diagnosis
Struma Ovarii*/surgery
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/surgery
Iodine*
Female ; Humans ; Adult ; Middle Aged
Czasopismo naukowe
Tytuł:
Diagnostic value of plasma-derived exosomal miR-223 for epithelial ovarian cancer.
Autorzy:
Yang L; Department of Obstetrics and Gynecology, Tangshan Workers' Hospital, Tangshan, China.
Yang Z; Department of Basic Medicine, Tangshan Vocational and Technical College, 120 Xinhua West Road, Lubei District, Tangshan, Hebei Province, 063000, China. .
Liu Z; Department of Obstetrics and Gynecology, Tangshan Workers' Hospital, Tangshan, China.
Qi N; Department of Obstetrics and Gynecology, Tangshan Workers' Hospital, Tangshan, China.
Tao L; Department of Obstetrics and Gynecology, Tangshan Workers' Hospital, Tangshan, China.
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2024 Mar 02; Vol. 24 (1), pp. 150. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/genetics
Exosomes*/metabolism
Exosomes*/pathology
MicroRNAs*
Humans ; Female ; Carcinoma, Ovarian Epithelial/diagnosis ; Sensitivity and Specificity ; Biomarkers, Tumor/metabolism ; CA-125 Antigen
Czasopismo naukowe
Tytuł:
Effect of angiogenesis inhibitors on wound healing in patients with ovarian cancer: A meta-analysis.
Autorzy:
Li X; School of medicine, Wuhan University of Science and Technology, Wuhan, China.
Zeng D; School of medicine, Wuhan University of Science and Technology, Wuhan, China.
Shi J; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
International wound journal [Int Wound J] 2024 Mar; Vol. 21 (3), pp. e14737.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Angiogenesis Inhibitors*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/chemically induced
Humans ; Female ; Angiogenesis ; Wound Healing
Czasopismo naukowe
Tytuł:
Giant cystic abdominal mass of struma ovarii: a diagnostic challenge.
Autorzy:
Ni YJ; Department of General Surgery, Beijing Yanqing Hospital of Traditional Chinese Medicine, Beijing, China.
Geng QL; Department of General Surgery, Beijing Yanqing Hospital of Traditional Chinese Medicine, Beijing, China.
Ye JS; Department of General Surgery/Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2024 Mar; Vol. 28 (3), pp. 331-333. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Case Reports
MeSH Terms:
Struma Ovarii*/diagnostic imaging
Struma Ovarii*/surgery
Ovarian Neoplasms*/diagnostic imaging
Ovarian Neoplasms*/surgery
Humans ; Female ; Abdomen ; Abdominal Muscles
Raport
Tytuł:
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Autorzy:
McPhail S; National Disease Registration Service, NHS England, Leeds, UK.
Barclay ME; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London, UK.
Johnson SA; Cancer Intelligence, Cancer Research UK, London, UK.
Swann R; National Disease Registration Service, NHS England, Leeds, UK; Cancer Intelligence, Cancer Research UK, London, UK.
Alvi R; Department of Epidemiology and Performance Measurement, Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Barisic A; Ontario Health (Cancer Care Ontario), Toronto, ON, Canada.
Bucher O; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada.
Creighton N; Cancer Institute NSW, St Leonards, NSW, Australia.
Denny CA; Public Health Scotland, Edinburgh, UK.
Dewar RA; Nova Scotia Health Cancer Care Program, Halifax, NS, Canada.
Donnelly DW; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Dowden JJ; Provincial Cancer Care Program, Eastern Health, St John's, NL, Canada.
Downie L; Public Health Scotland, Edinburgh, UK.
Finn N; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia; Cancer Support, Treatment and Research, Department of Health, Melbourne, VIC, Australia.
Gavin AT; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
Habbous S; Ontario Health (Cancer Care Ontario), Toronto, ON, Canada.
Huws DW; Welsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK; Population Data Science, Swansea University Medical School, Swansea, UK.
May L; Welsh Cancer Intelligence and Surveillance Unit, Public Health Data, Knowledge and Research Directorate, Public Health Wales, Cardiff, UK.
McClure CA; Prince Edward Island Cancer Registry, Queen Elizabeth Hospital, Charlottetown, PE, Canada.
Møller B; Cancer Registry of Norway, Oslo, Norway.
Musto G; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada.
Nilssen Y; Cancer Registry of Norway, Oslo, Norway.
Saint-Jacques N; Nova Scotia Health Cancer Care Program, Halifax, NS, Canada.
Sarker S; Department of Epidemiology and Performance Measurement, Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Shack L; Cancer Advanced Analytics, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada.
Tian X; Cancer Advanced Analytics, Cancer Research & Analytics, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada.
Thomas RJS; University of Melbourne, Parkville, VIC, Australia.
Thomson CS; Public Health Scotland, Edinburgh, UK.
Wang H; Provincial Cancer Care Program, Eastern Health, St John's, NL, Canada.
Woods RR; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
You H; Cancer Institute NSW, St Leonards, NSW, Australia.
Lyratzopoulos G; National Disease Registration Service, NHS England, Leeds, UK; Epidemiology of Cancer Healthcare & Outcomes, Department of Behavioural Science & Health, Institute of Epidemiology & Health Care, University College London, London, UK. Electronic address: .
Pokaż więcej
Corporate Authors:
ICBP Module 9 Chemotherapy Group
Źródło:
The Lancet. Oncology [Lancet Oncol] 2024 Mar; Vol. 25 (3), pp. 338-351.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Colonic Neoplasms*/drug therapy
Colonic Neoplasms*/epidemiology
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/epidemiology
Rectal Neoplasms*
Female ; Humans ; Benchmarking ; Liver ; Lung ; Ontario/epidemiology ; State Medicine ; Stomach ; Victoria ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Male
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies